C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 981-986

  Cimmino, Giovanni ^a   Ragni, Massimo ^b   Cirillo, Plinio ^c   Petrillo, Gianluca ^c   Loffredo, Francesco ^a   Chiariello, Massimo ^c   Gresele, Paolo ^d   Falcinelli, Emanuela ^d   Golino, Paolo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Umberto I Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acute coronary syndromes; CRP; MMP 9

Indexed keywords

C REACTIVE PROTEIN; ENZYME INHIBITOR; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE CORONARY SYNDROME; ADULT; AORTA; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INDUCTION; ENZYME RELEASE; FEMALE; HEART DISEASE; HEART RUPTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PLAQUE RUPTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; SMOOTH MUSCLE FIBER; STABLE ANGINA PECTORIS; TRANSCRIPTION INITIATION;

ACUTE CORONARY SYNDROMES; CRP; MMP-9;

ACUTE CORONARY SYNDROME; AGED; C-REACTIVE PROTEIN; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; UP-REGULATION;

EID: 84885308820     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.040     Document Type: Article

References (45)

1. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH. Unstable angina pectoris. N Engl J Med 2000;342:101-14.
2. Libby P. Current concepts of the pathogenesis of acute coronary syndromes. Circulation 2001;104:365-9.
3. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
4. Hansson GK, Libby P, Schonbeck U, Yan Z-Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-91.
5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53.
6. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 2009;54:669-77.
7. Michowitz Y, Arbel Y, Wexler D, et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol 2008;125:347-51.
8. Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure andmortality in survivors of acutemyocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006;47:962-8.
9. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004;116(Suppl. 6A):9S-16S.
10. KoenigW, SundM, FröhlichM, et al. C-reactive protein, a sensitivemarker of inflammation, predicts future risk of coronary heart disease in initially healthymiddle-agedmen: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg CohortStudy, 1984 to 1992. Circulation 1999;99:237-42.
11. Lowe GD. Local inflammation, endothelial dysfunction and fibrinolysis in coronary heart disease. Clin Sci (Lond) 2006;110:327-8 [12].
12. Calabrò P, Chang DW,Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005;46:1112-3.
13. Calabró P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003;108:1930-2.
14. De Rosa S, Cirillo P, Pacileo M, Di Palma V, Paglia A, Chiariello M. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res 2009;46:609-17.
15. Forte L, Cimmino G, Loffredo F, et al. C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int J Cardiol 2011;152:7-12.
16. Cirillo P, Golino P, Calabrò P, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005;68:47-55.
17. Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003;58:186-95.
18. Devaraj S, Xu Yan D, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003;107:398-404.
19. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
20. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerotic drugs. Circulation 2001;103:2531-4.
21. Verma S, Wang CH, Li SH, Dumont AS, Fedak PWM, Badiwala MV. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9.
22. Guo S,Meng S, Chen B, Liu J, Gao L,Wu Y. C-reactive protein can influence the proliferation, apoptosis, and monocyte chemotactic protein-1production of human umbilical vein endothelial cells. DNA Cell Biol 2011;30:157-62.
23. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9.
24. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82: 513-20.
25. Xie L, Chang L, Guan Y,Wang X. C-reactive protein augments interleukin-8 secretion in human peripheral blood monocytes. J Cardiovasc Pharmacol 2005;46:690-6.
26. Galve-de Rochemonteix B, Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 1993;53:439-45.
27. Agewall S.Matrixmetalloproteinases and cardiovascular disease. Eur Heart J 2006;27: 121-2.
28. Galis ZS. Matrix metalloproteinases in vascular remodelling and atherogenesis: the good, the bad and the ugly. Circ Res 2002;90:251-62.
29. Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 1998;3:199-206.
30. Gresele P, Falcinelli E, Loffredo F, et al. Platelets releasematrixmetalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. Eur Heart J 2011;32:316-25.
31. Granier G, Re My-Zolghadri M, Guignard R, et al. Isolation and culture of three vascular cell types from a small vein biopsy sample. In Vitro Cell 2003;39:131-9.
32. Thyberg J, Nilsson J, Palmberg L, Sjölund M. Adult human arterial smooth muscle cells in primary culture. Modulation from contractile to synthetic phenotype. Cell Tissue Res 1985;239:69-74.
33. Kleiner DE, Stetler-StevensonWG. Quantitative zymography: detection of pictogram quantities of gelatinases. Anal Biochem 1994;218:325-9.
34. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317-25.
35. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
36. Brown DL, Hibbs MS, Kearney Mm Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesion: association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-31.
37. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003;59:812-23.
38. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221-33.
39. deNooijer R, Verkleij CJ, von der Thüsen JH, et al. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 2006;26:340-6.
40. Chen F, Eriksson P, Hansson GK, et al. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 2005;15:57-65.
41. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
42. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-62.
43. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;30(105):2019-23.
44. Funayama H, Ishikawa SE, Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J 2004;68:451-4.
45. Fukuda D, Shimada K, Tanaka A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006;97:175-80.